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Children with cancer have high emergency department (ED) utilization, but little is 
known about their chief complaints. A retrospective chart review of ED chief complaints 
for children with cancer (actively receiving therapy) at Riley Hospital for Children from 
January 2014 to December 2015 was performed. Proportions of visits and disposition for 
top 5 chief complaints were determined. Multivariate logistic regression analyzed factors 
associated with admission. There were 598 encounters by 231 children with cancer. 
About half (49%) had more than one complaint. The five most common primary chief 
complaints were: fever (60.2%), pain (6.5%), nausea/vomiting (5.0%), bleeding (3.9%), 
and abnormal lab (3.3%). Admission rates varied, with the highest rates being for 
nausea/vomiting (66.7%). Risk factors for admission were: hospitalization in prior 4 
weeks (OR=2.67, CI 1.77-4.02), chief complaint of fever (OR=1.90, CI 1.16-3.09). For 
each increase in chief complaints, odds increased by 1.45 (CI 1.14-1.83). Black, non-
Hispanic (OR=0.44, CI 0.22-0.88) as compared to white, non-Hispanic, younger age 
(OR=0.53, CI 0.29-0.99) or complaint of abnormal lab (OR=0.20, CI 0.06-0.68) had 
lower odds of admission. Children with cancer present to the ED with multiple and varied 
complaints. Future interventions could aim to improve caregiver anticipatory guidance 













Emergency department utilization is higher among children with cancer than the 
general pediatric population.1,2 Children with cancer represent a unique population in 
terms of the reasons for seeking care in the ED. Previous publications have evaluated the 
reasons for ED visits by children with cancer via assessment of International 
Classification of Diseases, Ninth Revision, Clinical Modification discharge diagnoses.3,4 
Unfortunately, discharge diagnoses are not necessarily representative of the chief 
complaints that brought the child with cancer to the ED. A classic example of the 
difference between chief complaints and discharge diagnoses is if an adult presents with a 
complaint of chest pain, they may be diagnosed with a potentially fatal heart attack or a 
benign condition such as gastro-esophageal reflux.5 None of the currently available 
databases of ED utilization among children with cancer contain chief complaints, only 
discharge diagnoses, leading to a gap in our understanding of the complaints that prompt 
children with cancer to seek care in the ED.  
 
Therefore, the purpose of this study is to identify the spectrum of chief complaints 
among children with cancer presenting to a free-standing children’s hospital ED and 
evaluate factors associated with admission among this population. Our hypotheses were 
that children with cancer present to the ED with more than one chief complaint, with 
fever being the most common complaint and most associated with admission. Our 
investigation will lead to a better understanding of the signs and symptoms that cause 
children with cancer to seek care in the ED. 
 
Methods 
Study Design and Setting  
We performed a retrospective chart review of ED encounters for children with 
cancer at the Riley Hospital for Children Emergency Department at Indiana University 
Health from January 1, 2014 to December 31, 2015. The Riley Hematology-Oncology 
Clinic at Indiana University Health treats 80 percent of all new pediatric cancer diagnoses 
in Indiana and sees an average of 200 new cancer patients each year. The Riley 
Hospital’s Emergency Medicine and Trauma Center is a Level 1 Pediatric Trauma Center 
that provides care for over 34,000 children annually.  
 
Study Population/Database Development 
In order to create a database of all children with cancer seen at the Riley ED, we 
first obtained ED visit logs for all ED visits to the Riley Hospital for Children from the 
electronic medical record. Second, children with cancer were extracted using a clinical 
patient database maintained by the pediatric oncology clinical research office. Inclusion 
criteria for this study required an ED visit by a child with cancer actively receiving 
treatment, including either chemotherapy and/or radiation. ED encounters were excluded 
if the visit was for a new diagnosis of cancer, a relapse of cancer, or occurred prior to the 
cancer diagnosis. We then created a database of ED visits by children with cancer by 
extracting patient characteristics and ED encounter information from the clinical patient 
database and the electronic medical record.  
 
 Patient demographic characteristics included gender, age category, race/ethnicity 
(White, Non-Hispanic; Black, Non-Hispanic; Hispanic; and Other), primary payer 
(Public/governmental, Private, Self-pay). Patients were classified into one of the 
following types of cancer based on electronic medical record data: acute lymphoblastic 
leukemia (ALL), acute myelogenous leukemia (AML), central nervous system tumors 
(CNS), solid tumors (non-CNS), Hodgkin lymphoma, and non-Hodgkin lymphoma. 
Patients with non-specified malignancies or rare cancers were placed into an “Other” 
category. Encounter characteristics included chief complaints (including a primary chief 
complaint and then all secondary complaints), whether or not there was an inpatient 
encounter within the prior 4 weeks, ED disposition (admit vs discharge), and which unit 
the patient was admitted to (floor status versus pediatric intensive care unit). We chose to 
include an inpatient encounter within the prior 4 weeks because readmissions have been 
the focus of quality improvement and cost containment in the era of the Patient Protection 
and Affordable Care Act.6 We chose not to evaluate the reason for the previous inpatient 
visit since our focus was primarily on the reasons for ED visits. 
 
There were 41 encounters with missing primary payer information, which 
accounted for about 7% of encounters, these were included in all analyses except the 
logistic regression.  
 
Outcome and Exploratory Variables 
We reviewed all listed chief complaints and those with a similar clinical focus 
were condensed into chief complaint categories. Each encounter could have more than 
one complaint associated with it, the highest number of complaints found on chart review 
were five complaints so that was the maximum we collected for each encounter. For the 
logistic regression, the primary outcome of interest was whether an ED visit resulted in 
admission to Riley Hospital for Children versus discharged to home (patient treated then 
released from the ED).  
 
Statistical Analyses 
We summarized encounter characteristics using frequencies and percentages. We 
compared characteristics of those who were admitted versus discharged using chi-square 
analyses. We evaluated the number of ED visits per patient and the number of total chief 
complaints per visit. We separated primary chief complaints from secondary complaints 
and generated a rank list for each. Then, the top 5 primary chief complaints were 
presented as proportion of visits, both overall and by type of cancer. Proportions of 
hospitalization rates were calculated, both overall and by the top 5 primary chief 
complaints.  
 
A multivariate logistic regression model was used to estimate factors associated 
with admission for children with cancer. Variables were included based on our defined 
model: patient’s gender, age category, race/ethnicity, primary expected payer, whether 
there was an inpatient visit in the prior 4 weeks, the number of chief complaints as a 
continuous variable, and dichotomous variables for the presence or absence of each of the 
top 5 most common primary chief complaints. All analyses were performed using SAS 
9.4 (Carey, NC), and p-values <0.05 were considered statistically significant. 
 Results 
 Overall, there were 598 encounters by 231 children with cancer during the two-
year time frame investigated. Only 40.3% of children had just 1 ED visit, 23.8% had 2 
visits, 12.1% had 3 visits, and 23.8% had 4 or more visits. We present the encounter level 
characteristics of the ED visits among children with cancer in Table 1, both overall and 
by ED disposition status. There were significant differences between age groups who 
were admitted compared to discharge with higher proportions of younger patients 
discharged. Similarly, a higher proportion of black, non-Hispanic patients were 
discharged. About half of visits were by children with public/governmental primary 
insurance payer (51.9%). Other common characteristics included a diagnosis of ALL 
(41.3%) and been hospitalized in the prior 4 weeks (53.2%). Of these encounters, 43.5% 
resulted in discharge to home and 56.5% were admitted to the hospital. Among the 
admissions, 93.8% were admitted to the inpatient floor and 6.2% were admitted to the 
pediatric intensive care unit.  
 
Emergency department chief complaints 
About half of children with cancer (51%) had only one chief complaint while 
30.9% had 2 complaints (Figure 1). The five most common primary chief complaints 
prompting an ED visit for children with cancer are presented in Table 2. Fever was the 
most common primary chief complaint (60.4%); followed by pain (6.1%), 
nausea/vomiting (5.1%), bleeding (3.9%) and abnormal lab (3.4%). When we evaluated 
the chief complaints by type of cancer, fever remained the most common ED visit chief 
complaint for all types of patients; ALL (66.0%), solid tumor (60.2%), CNS tumor 
(44.8%), NHL (70.0%), Hodgkin lymphoma (57.9%), and AML (60.0%). The top 5 
secondary complaints included: cough (16.4%), nausea/vomiting (11.9%), pain (8.2%), 
rhinorrhea (6.9%), and headache (4.2%).  
 
Admission rates by chief complaint 
Overall, 56.5% (N=338) of ED encounters resulted in an inpatient admission. 
Admission rates varied by the top 5 primary chief complaints with nausea and vomiting 
having the highest (66.7%) and abnormal lab with the lowest (20%) (Figure 2).  
 
Factors Affecting Admission from the ED Among Children with Cancer 
In a multivariate analysis, factors associated with significantly increased odds of 
admission included having a chief complaint of fever (OR=1.90, CI 1.16-3.09) and 
having been hospitalized in the prior 4 weeks (OR=2.67, 95% CI 1.77-4.02) compared 
with not having a recent admission. For each increase in the number of chief complaints, 
the likelihood of admission increased by 1.45 (95% CI 1.14-1.83). Younger patients (ages 
0-4 years) had lower odds of admission (OR=0.53, CI 0.29-0.99) than older children 
(ages 15-20+ years). Black, non-Hispanic patients were less likely to be admitted 
(OR=0.44, CI 0.22-0.88) as compared to white, non-Hispanic. Patients with a primary 
chief complaint of abnormal lab also had significant decreased odds of admission 




In this retrospective study, children with cancer who are actively receiving 
therapy not only present to the ED with a wide range of complaints, but also tend to have 
more than one complaint. The most common ED chief complaint was fever, followed by 
pain, nausea/vomiting, bleeding and abnormal lab. Importantly, the majority of ED visits 
resulted in admission, with the highest rates of admission for a chief complaint of 
nausea/vomiting or fever. Factors associated with increased odds of admission included a 
chief complaint of fever, having a recent hospitalization, and having more than one 
complaint. This analysis highlights the undesired, but not unexpected side effects of the 
cancer therapies leading to ED visits for children with cancer. This information provides 
specific focus areas for future interventions aimed at providing caregivers of children 
with cancer improved anticipatory guidance and preparedness when an ED visit is 
necessary.   
 
Fever is a significant ED complaint and discharge diagnosis for children with 
cancer with increased odds of admission.3.4 Unfortunately, in the field of pediatric 
oncology we lack agreement on the exact definition of a fever.7,8 This leads to difficulties 
in creating evidence-based clinical practice guidelines and differences in triaging and 
management practices, as demonstrated in a previous study of pediatric oncology 
providers in Michigan.9 In order to unify our approach and move towards implementation 
of validated risk prediction models to evaluate the risk of serious infection in the setting 
of fevers,10,11 a consensus on the definition of fever among children with cancer would be 
beneficial. At a minimum, it would be prudent for each institution to develop a clinical 
practice guideline with an agreed upon definition of fever in order to decrease confusion 
among patients, caregivers, providers, and staff.  
 
Chemotherapy-induced nausea and vomiting (CINV) was the third major chief 
complaint that brought children with cancer to the emergency department. Inadequate 
control of CINV are among the most severe and bothersome side effects experienced by 
children with cancer according to their parents.12 Several recent updates on guidelines for 
CINV outline key changes in recommendations for both acute, anticipatory, breakthrough 
and refractory CINV.13,14 An important consideration for CINV is to understand whether 
these new evidence-based recommendations are being implemented by oncologists in the 
clinical setting. Also, attention should focus on the ability of caregivers of children with 
cancer to manage CINV in the home setting. A lack of caregiver education or appropriate 
at-home medications for breakthrough nausea will inhibit optimal supportive care.    
 
Pain is not only an unfortunately common experience for children with cancer,15,16 
but one which leads to ED visits. Pain can come from a variety of sources for this unique 
population; from complications of their malignancy (i.e. bone pain, tumor compression), 
post-operative pain, and the pain experienced during their treatment (i.e. central line 
accessing, mucositis, neuropathy). Therefore, pain assessment has been identified as an 
important quality measure for the outpatient care of children with cancer.17 It is essential 
that we not only assess pain in this unique population, but also provide sufficient 
anticipatory guidance for caregivers along with at-home prescription medications. 
Improved at-home pain management strategies could decrease ED reliance and improve 
quality of life.   
 
Secondary complaints of cough and rhinorrhea could represent a simple viral 
upper respiratory infection or be signs of a more serious bacterial or fungal infection such 
as sinusitis or pneumonia. Recently published guidelines for management of fevers in 
children with cancer highlight that further research is needed to evaluate if viral processes 
increase the risk for serious infections in this population.8 Of note, in a previous analysis 
of discharges for fever and neutropenia, encounters with a short length of stay (less than 
or equal to 3 days) were associated with a discharge diagnosis of a viral illness.18,19 This 
suggests that if patients with cough or rhinorrhea are admitted for evaluation and no 
serious bacterial infection is found, they are more likely to be discharged after only a few 
days. Further evaluation could investigate if there are associated signs or symptoms with 
rhinorrhea and cough that could aid in outpatient triaging and decrease ED visits.  
 
Limitations 
There are several important limitations to our study. First, this was a single 
institution study, but we have approximately 200 new diagnoses of childhood cancer per 
year at Riley Hospital for Children and are similar to many other large, quaternary, free-
standing children’s hospitals. Second, due to the large geographical spread of our patient 
population across the entire state of Indiana, this analysis may not represent all ED visits 
by our patient population as those who live far from Riley Hospital and may have 
received care at local hospitals. Third, our goal was to explore chief complaints as 
documented in the medical record and we did not evaluate the highest documented or 
observed temperatures, thus the definition of “fever” was based on chief complaint report 
only. Also, we appreciate that admissions to the intensive care unit represent a higher 
level of clinical severity, but we did not have a large enough sample to evaluate 
differences in factors of admission to the intensive care unit versus the inpatient floor. 
Also, we did not explore factors associated with whether the admissions were considered 
“unplanned,” but this line of quality improvement could be the focus of future 
investigations. Nevertheless, this study represented a large number of ED visits to our 




In this retrospective review of ED visits among children with cancer who are 
actively receiving therapy, we revealed that children with cancer not only present to the 
ED with a wide range of complaints, but also tend to have more than one complaint. The 
five most common complaints for ED visits were fever, pain, nausea/vomiting, bleeding 
and abnormal lab. Factors associated with increased odds of admission included a chief 
complaint of fever and having more than one complaint. Future evaluations should focus 
on the adequacy of current management strategies through incorporation of patient and 
caregiver perspectives.   
 
Conflict of Interest statement: All authors have no conflicts of interest to disclose.  
Acknowledgements: None  
References 
 
1. O'Sullivan C, Dupuis LL, Gibson P, et al. Refinement of the symptom screening 
in pediatrics tool (SSPedi). Br J Cancer 2014:111(7):1262-1268. 
2. National Center for Health Statistics. Health, United States, 2015: With Special 
Feature on Racial and Ethnic Health Disparities. Hyattsville, MD. 2016. 
3. Mueller EL, Sabbatini A, Gebremariam A, et al. Why pediatric patients with 
cancer visit the emergency department: United States, 2006-2010. Pediatr Blood 
Cancer 2015:62(3):490-495. 
4. Mueller EL, Hall M, Shah SS, et al. Characteristics of Children With Cancer 
Discharged or Admitted From the Emergency Department. Pediatr Blood Cancer 
2016:63(5):853-858. 
5. Chan S, Maurice AP, Davies SR, et al. The use of gastrointestinal cocktail for 
differentiating gastro-oesophageal reflux disease and acute coronary syndrome in 
the emergency setting: a systematic review. Heart Lung Circ 2014:23(10):913-
923. 
6. Centers for Medicare and Medicaid Services. Readmissions Reduction Program 
2013. http://www.cms.gov/Medicare/Medicare-Fee-for-
ServicePayment/AcuteInpatientPPS/Readmissions-Reduction-Program.html. 
Accessed March 1, 2018 
7.  Haeusler GM, Phillips RS, Lehrnbecher T, et al. Core outcomes and definitions 
for pediatric fever and neutropenia research: A consensus statement from an 
international panel. Pediatr Blood Cancer 2015:62(3):483-489. 
8. Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the Management of 
Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell 
Transplantation Recipients: 2017 Update. J Clin Oncol 2017:35(18):2082-2094. 
9. Mueller EL, Walkovich KJ, Yanik GA, et al. Variation in Management of Fever 
and Neutropenia Among Pediatric Patients With Cancer: A Survey of Providers in 
Michigan. Pediatr Hematol Oncol 2015. 
10. Haeusler GM, Thursky KA, Mechinaud F, et al. Predicting Infectious 
ComplicatioNs in Children with Cancer: an external validation study. Br J Cancer 
2017:117(2):171-178. 
11. Phillips RS, Sung L, Amman RA, et al. Predicting microbiologically defined 
infection in febrile neutropenic episodes in children: global individual participant 
data multivariable meta-analysis. Br J Cancer 2016:114(6):623-630. 
12. Dupuis LL, Milne-Wren C, Cassidy M, et al. Symptom assessment in children 
receiving cancer therapy: the parents' perspective. Support Care Cancer 
2010:18(3):281-299. 
13. Flank J, Robinson PD, Holdsworth M, et al. Guideline for the Treatment of 
Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea 
and Vomiting in Children With Cancer. Pediatr Blood Cancer 2016:63(7):1144-
1151. 
14. Patel P, Robinson PD, Thackray J, et al. Guideline for the prevention of acute 
chemotherapy-induced nausea and vomiting in pediatric cancer patients: A 
focused update. Pediatr Blood Cancer 2017. 
15. Dupuis LL, Sung L, Molassiotis A, et al. 2016 updated MASCC/ESMO 
consensus recommendations: Prevention of acute chemotherapy-induced nausea 
and vomiting in children. Support Care Cancer 2017:25(1):323-331. 
16. Van Cleve L, Bossert E, Beecroft P, et al. The pain experience of children with 
leukemia during the first year after diagnosis. Nurs Res, 2004;53:1-10. 
17. Teichman J, Punnett A, Gupta S. Development of Quality Metrics to Evaluate 
Pediatric Hematologic Oncology Care in the Outpatient Setting. J Pediatr 
Hematol Oncol 2017:39(2):90-96. 
18. Mueller EL, Croop J, Carroll AE. Fever and neutropenia hospital discharges in 
children with cancer: A 2012 update. Pediatr Hematol Oncol 2016:1-10. 
19. Mueller EL, Walkovich KJ, Mody R, et al. Hospital discharges for fever and 






Figure 1. Number of Chief Complaints for Children with Cancer per Emergency Department 
Encounter 
 
Figure 2. Emergency Department Admission Rates Among Children with Cancer, Overall and by 
Top 5 Primary Chief Complaints  
 
TABLE 1. Encounter Level Characteristics of Emergency Department Visits for Children with Cancer  
 
 Overall  Admitted Discharged p-value 
 N=598 N=338 (56.5) N=260 (43.5)  
 N (%)  
Gender  
   Female 240 (40.1) 138 (40.8) 102 (39.2) 0.69 
   Male 358 (59.9) 200 (59.2) 158 (60.8)  
Age Category 
   0-4 years 223 (37.3) 118 (34.9) 105 (40.4) 0.040 
   5-9 years 172 (28.8) 89 (26.3) 83 (31.9)  
   10-14 years 108 (18.1) 68 (20.1) 40 (15.4)  
   15-20+ years 95 (15.9) 63 (18.6) 32 (12.3)  
Race/Ethnicity  
   White, Non-Hispanic 450 (75.3) 258 (76.3) 192 (73.9) 0.003  
   Hispanic 77 (12.9) 47 (13.9) 30 (11.5)  
   Black, Non-Hispanic 55 (9.2) 20 (5.9) 35 (13.5)  
   Other 16 (2.7) 13 (3.9) 3 (1.2)  
Primary Payer*     
   Public/ Governmental 289 (51.9) 153 (49.2) 136 (55.3) 0.30 
   Private 258 (46.3) 153 (49.2) 105 (42.7)  
   Self-pay 10 (1.8) 5 (1.6) 5 (2.0)  
Type of Cancer  
   Acute Lymphoblastic Leukemia  247 (41.3) 130 (38.5) 117 (45.0) 0.37  
   Solid Tumor 206 (34.5) 127 (37.6) 79 (30.4)  
   Central Nervous System Tumor  96 (16.1) 53 (15.7) 43 (16.5)  
   Non-Hodgkin Lymphoma 20 (3.3) 14 (4.1) 6 (2.3)  
   Hodgkin Lymphoma 19 (3.2) 10 (3.0) 9 (3.5)  
   Acute Myelogenous Leukemia 5 (0.8) 2 (0.6) 3 (1.2)  
   Other                                       5 (0.8) 2 (0.6) 3 (1.2)  
Inpatient Encounter in Prior 4 Weeks 
    Yes 318 (53.2) 207 (61.2) 111 (42.7) <0.001 
    No 280 (46.8) 131 (38.8) 149 (57.3)  
Admit Unit 
   Floor  317 (93.8)   
   Pediatric ICU  21 (6.2)   
*There were 41 encounters with missing primary payer information. The remainder of the variables were 
complete for each encounter.  
 
  
TABLE 2.  Top Primary Chief Complaints Prompting ED Visits Among Children with Cancer – Overall 
and by Cancer Type 
 
  Overall By cancer type 
  












Rank  % by column 
1 Fever 60.2 66.0 60.2 44.8 70.0 57.9 60.0 
2 Pain 6.5 6.1 6.8 4.2 5.0 10.5 0 
3 Nausea/Vomiting 5.0 4.1 5.3 8.3 5.0 0 0 
4 Bleeding 3.9 3.2 5.3 4.2 0 0 0 
5 Abnormal Lab 3.3 2.8 2.4 6.3 10.0 0 0 
 
ALL=Acute lymphoblastic leukemia, CNS=Central nervous system, NHL=Non-Hodgkin lymphoma, 






TABLE 3. Multivariate Logistic Regression to Evaluate Factors Associated with Admission Versus 
Discharge from the ED Among Pediatric Cancer Patients 
 
Factors        Adj. Odds Ratio (OR) 95% CI p-value 
Patient Characteristics 
Gender 
  Female 1.04 0.70-1.56 0.84 
Age 
   15-20+ years Ref  
   10-14 years 1.01 0.50-2.0 0.99 
   5-9 years 0.55 0.29-1.06 0.07 
   0-4 years 0.53 0.29-0.99 0.046 
Race/Ethnicity    
   White, Non-Hispanic Ref   
   Black, Non-Hispanic 0.44 0.22-0.88 0.021 
   Hispanic 1.76 0.97-3.21 0.07 
   Other 2.87 0.73-11.28 0.13 
Type of cancer    
   Acute Lymphoblastic Leukemia Ref   
   Acute Myelogenous Leukemia 0.52 0.07-4.02 0.53 
   Solid Tumors 1.31 0.81-2.12 0.28 
   Central Nervous System Tumor  1.51 0.81-2.81 0.20 
   Hodgkin Lymphoma 0.69 0.22-2.14 0.52 
   Non-Hodgkin Lymphoma 1.74 0.56-5.45 0.34 
   Other 0.53 0.07-4.06 0.54 
Primary Payer    
   Public/ Governmental Ref   
   Private 1.07 0.69-1.64 0.77 
   Self 0.71 0.17-2.86 0.63 
ED Visit Characteristics 
Number of Chief Complaints    
 1.45 1.14-1.83 0.002 
Top 5 Primary Chief Complaint Categories (in rank order) 
   Fever 1.90 1.16-3.09 0.010 
   Pain 1.78 0.78-4.05 0.17 
   Nausea or vomiting 1.88 0.72-4.91 0.20 
   Bleeding 0.49 0.17-1.41 0.19 
   Abnormal Lab 0.20 0.06-0.68 0.010 
Inpatient in the last 4 weeks    
   Yes 2.67 1.77-4.02 <0.001 
ED=Emergency Department 
Bold indicates significant factors associated with admission versus discharge 
 
